tirzepatide application HypoSpray® New generic versions of tirzepatide

Researchers at Weill Cornell Medicine in New York evaluated if tirzepatide was associated with incident or progressive diabetic retinopathy and related complications using data from a large multicenter electronic health-record network

Also, DWAT is a source of estrogen production and treatment with GLP-1RA reduces those aging protective hormones due to DWAT loss [13] (Fig

Unfortunately, the current trend is completely the opposite, with a steady increase in overweight and obesity affecting the youngest, putting them at very high risk of developing a veritable epidemic of cardiometabolic diseases in a few years (see our article on this subject)

Daniel Drucker was awarded a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications, including Ozempic, Wegovy and Mounjaro